Cargando…

Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease

The composition of the gut microbiome is altered in patients with chronic kidney disease (CKD). Dysbiosis leads to decreased levels of stool organic acids (OAs) and systemic inflammation, followed by accumulation of uremic toxins (UTs) and the development of end-stage kidney disease (ESKD). We asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koshida, Takeo, Gohda, Tomohito, Sugimoto, Takuya, Asahara, Takashi, Asao, Rin, Ohsawa, Isao, Gotoh, Hiromichi, Murakoshi, Maki, Suzuki, Yusuke, Yamashiro, Yuichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380578/ https://www.ncbi.nlm.nih.gov/pubmed/37511232 http://dx.doi.org/10.3390/ijms241411456

Ejemplares similares

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis
por: Gohda, Tomohito, et al.
Publicado: (2017)

Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice
por: Ichikawa, Saki, et al.
Publicado: (2020)

The sodium–glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice
por: Li, Zi, et al.
Publicado: (2020)

Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease
por: Murakoshi, Maki, et al.
Publicado: (2020)

Progranulin and Its Receptor Predict Kidney Function Decline in Patients With Type 2 Diabetes
por: Murakoshi, Maki, et al.
Publicado: (2022)

Circulating kidney injury molecule‐1 as a biomarker of renal parameters in diabetic kidney disease
por: Gohda, Tomohito, et al.
Publicado: (2019)

Sodium-Glucose Cotransporter-2 Inhibitors—Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials
por: Gohda, Tomohito, et al.
Publicado: (2022)

Differential organ-specific inflammatory response to progranulin in high-fat diet-fed mice
por: Murakoshi, Maki, et al.
Publicado: (2021)

Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function
por: Gohda, Tomohito, et al.
Publicado: (2020)

Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients
por: Gohda, Tomohito, et al.
Publicado: (2022)

Postmortem computed tomography of gas gangrene with aortic gas in a dialysis patient
por: Asao, Rin, et al.
Publicado: (2020)

Association of the Cardioankle Vascular Index and Ankle-Brachial Index with Carotid Artery Intima Media Thickness in Hemodialysis Patients
por: Gohda, Tomohito, et al.
Publicado: (2013)

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy
por: Maruyama, Shuntaro, et al.
Publicado: (2016)

Role of Mindin in Diabetic Nephropathy
por: Murakoshi, Maki, et al.
Publicado: (2011)

Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes
por: Kamei, Nozomu, et al.
Publicado: (2018)

Diet, Gut Microbiome, and Their End Metabolites Associate With Acute Pancreatitis Risk
por: Yazici, Cemal, et al.
Publicado: (2023)

Malnutrition- inflammation- atherosclerosis (MIA) syndrome associates with periodontitis in end-stage renal disease patients undergoing hemodialysis: a cross-sectional study
por: Mikami, Risako, et al.
Publicado: (2023)

Gastrorenal shunt: a cause of hyperammonemia
por: Nakamura, Yuya, et al.
Publicado: (2017)

Microbiome Metabolites and Thyroid Dysfunction
por: Bargiel, Piotr, et al.
Publicado: (2021)

Association of type 2 diabetes with periodontitis and tooth loss in patients undergoing hemodialysis
por: Mikami, Risako, et al.
Publicado: (2022)

Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
por: Yabuuchi, Junko, et al.
Publicado: (2020)

The Role of the Microbiome and Microbiome-Derived Metabolites in Atopic Dermatitis and Non-Histaminergic Itch
por: Li, Wei, et al.
Publicado: (2020)

Editorial: Microbiome metabolites in health and disease
por: Canfora, Emanuel E., et al.
Publicado: (2023)

The lung microbiome in end-stage Lymphangioleiomyomatosis
por: Ng, Julie, et al.
Publicado: (2021)

Impact of sleep on the microbiome of oral biofilms
por: Sotozono, Maki, et al.
Publicado: (2021)

The Effects of Immunosuppression on the Lung Microbiome and Metabolites in Rats
por: Dong, Huiwei, et al.
Publicado: (2022)

Local and systemic effects of microbiome‐derived metabolites
por: Spivak, Igor, et al.
Publicado: (2022)

Role of the microbiome and its metabolites in ankylosing spondylitis
por: Song, Zi-Yi, et al.
Publicado: (2022)

Taxonomic classification for microbiome analysis, which correlates well with the metabolite milieu of the gut
por: Wakita, Yoshihisa, et al.
Publicado: (2018)

Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs
por: Sakuma, Hiroko, et al.
Publicado: (2020)

The Impact of Human Parvovirus B19 Infection on Heart Failure and Anemia with Reference to Iron Metabolism Markers in an Adult Woman
por: Nakamura, Yuya, et al.
Publicado: (2017)

Effect of Exercise on Kidney Function, Oxidative Stress, and Inflammation in Type 2 Diabetic KK-A(y) Mice
por: Ishikawa, Yuji, et al.
Publicado: (2012)

Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites
por: Malczewski, Agnieszka Beata, et al.
Publicado: (2021)

Microbiome and One Health: Potential of Novel Metabolites from the Gut Microbiome of Unique Species for Human Health
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2023)

Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
por: Oh, Ki-Kwang, et al.
Publicado: (2022)

Association Between Kidney Function Decline and Baseline TNFR Levels or Change Ratio in TNFR by Febuxostat Chiefly in Non-diabetic CKD Patients With Asymptomatic Hyperuricemia
por: Gohda, Tomohito, et al.
Publicado: (2021)

Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
por: Kaddurah-Daouk, Rima, et al.
Publicado: (2011)

The Environment of Regulatory T Cell Biology: Cytokines, Metabolites, and the Microbiome
por: Hoeppli, Romy E., et al.
Publicado: (2015)

Serotonin and tryptophan metabolites, autoantibodies and gut microbiome in APECED
por: Naskali, Emmi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rn0vkpntf1e978ird9kklbsh4s